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I. Introduction
The Common Rule is the federal regulatory scheme
for the protection of human subjects in research.' It
requires that most medical research involving human
subjects undergo review by an Institutional Review
Board (IRB) and be subject to robust informed consent procedures. However, certain categories of
research are considered so low risk as to be exempt
from the regulation.2
Significant portions of health research are exempt.
For example, behavioral research about how physicians understand scientific information, and about
why patients may fail to adhere to treatment regimens, often relies on interviews or surveys of patients
or physicians.3 A considerable body of epidemiological
and health economic research uses existing data, anonymized to protect patient privacy - another exempt
category.4 Studies of Medicaid and Medicare, as public
benefit programs, are exempt too. Proposed changes
to the Common Rule would add research using bioJonathan D. Loe, J.D., is a Fellow in Regulatory Science at
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specimens to the exempt categories, an important
area given the successes of genomic research and the
potential for personalized medicine.6
Exempt and non-exempt research are substantially different. Fundamentally, the entire Common
Rule - the nexus of federal regulation of researchis inapplicable to exempt research projects. For
exempt research, federal law does not require elaborate informed consent procedures or documentation
thereof.6 Thus, exempt projects do not require local
oversight by an IRB, which means that these projects
can be administered more quickly and more flexibly.
For even relatively minor changes to a recruitment
protocol or survey instrument, non-exempt research
requires full IRB approval, and even without changes,
requires "continuing review" at least once per year.7
Overall, an exempt project can be started more
quickly, can be changed more flexibly, and can have
fewer documentation requirements than non-exempt
research.
Federal regulations provide criteria for determining
whether research is exempt, but do not currently specify a procedure for making that determination. The
Department of Health & Human Services ("DHHS")
Office of Human Research Protections ("OHRP")
does recommend that researchers not be permitted
to make that determination themselves., In practice,
local IRBs and their staff do so instead. Thus, unlike a
determination that a given project is not human subjects research at all-which puts it outside the Common
Rule - "exemption" currently functions as a third
level of IRB review, below expedited and full review.
Changes to this system were recently proposed by
DHHS. Together with the other federal agencies that
implement the Common Rule, it announced a Notice
of Proposed Rulemaking ("NPRM") that would signifi-
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cantly revise portions of that rule.9 It would add new
categories of exempt research, exclude from regulation some currently exempt research, and change the
exemption procedure to allow researchers to make
exemption determinations themselves, using a DHHSprovided web form that has not yet been completed.o
To inform these proposed revisions and provide a
basis for developing a universal form, our research
team sought to assess the current state of how exempt
research is reviewed and regulated. We conducted
an empirical review of the policies and procedures of
the top 50 institutions - based on total NIH funding in the past year - for reviewing putatively exempt
research. We found wide and unexplained variation

tions and a Federal Demonstration Partnership effort
to pilot such a form.
II. Background
Section 289 of title 42 of the United States Code
requires DHHS to enact regulations that mandate the
establishment of an IRB at every institution receiving federal funding for human subjects research, to
review such research." In response, the DHHS established the Common Rule, 45 C.F.R. 46 Part A. It is
the principal federal effort to ensure the protection
of the human participants in research, and provides
the framework for efforts to ensure that individual
researchers design protocols that effectively balance

To inform these proposed revisions and provide a basis for developing a
universal form, our research team sought to assess the current state of how
exempt research is reviewed and regulated. We conducted an empirical review
of the policies and procedures of the top 50 institutions - based on total
NIH funding in the past year - for reviewing putatively exempt research. We
found wide and unexplained variation across these institutions. Further, we
found that the current submission and review procedures at many institutions
impose significantly more responsibilities on investigators than those required
at other institutions, without clear benefits to subjects. The DHHS's proposed
rule changes are thus a timely reform. We therefore look to some specifics of
institutional forms for insight into how DHHS might design its standard form.
across these institutions. Further, we found that the
current submission and review procedures at many
institutions impose significantly more responsibilities
on investigators than those required at other institutions, without clear benefits to subjects. The DHHS's
proposed rule changes are thus a timely reform. We
therefore look to some specifics of institutional forms
for insight into how DHHS might design its standard
form.
In Section II of this paper, we lay out the legal
framework surrounding IRB regulation of exempt
research. In Section III, we describe the methods we
used in conducting our study. In Section IV we lay
out the results of our study. In Section V we describe
the conclusions that can be drawn and some possible reforms for IRBs to reduce unnecessary work
for researchers while still effectively protecting the
interests of research subjects. In Section VI we discuss
DHHS's proposed template for exemption determina-
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the risks to subjects with the goals of the research.
Because so much research relies upon human participation, ensuring those participants' safety is a powerful concern, of importance not just to the individuals,
but to the research enterprise.
The Common Rule applies to all human subjects
research conducted, supported, or subject to regulation by any federal department unless exempted
under section 46.101(b). The OHRP requires all
covered institutions to provide assurances that the
IRB will review human subjects research and ensure
that the research complies with regulations, unless
12

the research is exempt.1 3 OHRP recommends that

the institution have clear policies in place for the IRB
or some other authority to determine if the research
constitutes exempt human subjects research.14 It

also requires an accurate determination so that nonexempt research is reviewed, and monitors whether
institutions are compliant.15
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The exempt categories function as safe harbors for
categories of research that are considered low-risk.
The general categories that qualify as exempt human
research are those that:
(1) Involve normal educational practices conducted in established or commonly accepted
educational settings.
(2) Involve the use of educational tests, survey
procedures, interview procedures, or observation of public behavior where information
is not identifiable or damaging.
(3) Involve the use of educational tests, survey
procedures, interview procedures, or observation of public behavior of public officials
or where federal statute requires continued
confidentiality.
(4) Involve collection or study of existing data,
documents, records, or pathological or
diagnostic specimens if sources are publicly
available or if information is recorded so that
subjects cannot be identified.
(5) Study, evaluate, or examine public benefit
or service programs or changes to those
programs.
(6) Involve taste and food quality evaluation or
consumer acceptance studies.1 6
Any research falling into one of the above categories is
exempt.17 Other than the OHRP's non-binding recommendation that "investigators not be given the authority to make an independent determination,"s nothing
in the regulations specifies who must make the determination that given research is exempt - under the
law and regulations alone, a researcher could conceivably find that her own research meets an exemption and then move forward without any form of IRB
oversight.
Nevertheless, in practice, things are not that simple.
Previous research has shown wide variation in IRB
decision-making, both at a policy,19 and individual
project level.20 In multicenter studies, some IRBs have
accorded projects exempt status quickly, while others have taken so long to review the research that the
researchers gave up on that center. 21 IRBs have been
criticized as arbitrary and capricious decision-makers, 22 with a recent book-length treatment of the subject sharpening the point.23 Despite this, no study that
we could find directly analyzes IRB policies regarding
exempt research, or their effects on researchers.
This is especially surprising considering the effect
of an exempt determination. Not only does exempt
research not require IRB review, it is exempt from all
the requirements of the Common Rule. 45 C.F.R. §

46.101(a), (b). Although institutions and funders may
impose other restrictions on such research, exempt
researchers are generally then free to go about their
research. Given this potential vacuum of oversight,
it is important to assess the processes used to award
such status.

III. Methods
We began by accessing a list of the top 50 research
institutions by receipt of NIH funding in 2015.24
The quantity of funding acts as a rough proxy of the
amount of health-related human subjects research
being undertaken at each institution. We attempted
to find the relevant IRB for each entity listed to code
the appropriate form and policy. A research assistant
(RA) identified each institution's website for its IRB
and searched relevant documents until they found the
relevant forms required. The assistant also provided
links to the document, and extracted the relevant
text of the policy or guideline, along with a URL and
citation.
Five modes of analysis were used. First, the RA
independently coded all 50 institutions with regard to
what forms they required for review of a putativelyexempt study. Five categories were used:
1. No application required for exempt research.
2. Specific form required for exempt research.
3. Main application is adapted/shortened for
exempt research.
4. Completion of full IRB form required.
5. Main form plus additional documentation
required.
Table 1 below lists examples of institutions in each of
these categories. We acknowledge some implicit inferences entailed in the distinction between categories 3
and 4. For example, even full forms for non-exempt
research may contain fields that are irrelevant and can
be left incomplete by investigators. For category 3,
the distinction we drew was whether the institutional
form or policy specifically directed the investigator to
ignore parts of the form if the research was putatively
exempt.
Compliance staff and IRBs may also diverge from
written policy - for example, in practice requiring
less information than the form itself would seem to
address. Our review would not capture such practices.
For the purposes of this analysis, we focused solely on
the policy as written and published to investigators.
After coding each institution into one of the five categories, we then calculated frequencies for each of the
five possibilities to determine the variation amongst
institutions. Four institutions could not be coded
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Table I
Form Codes with Examples of Form Language

Code

Institution

Form Language

I. No submission

None

None

2. Specific form

Johns Hopkins
University

"Researchers must complete and submit to HIRB an Application for Exemption or an Application for Expedited/Full
Board Review."

3.Adapted main form

Northwestern
University

"You are encouraged to use the checklists to write your
Investigator Protocol in a way that addresses the criteria
for approval... .Criteria for IRB approval can be found in the
"WORKSHEET: Exemption (HRP-312)" for exempt Human
Research."

4. Full form

University of North

"Regardless of review type, all applications use the same online submission form."

5. More than full form

Columbia University
Health Sciences

because it was not possible to find their forms or policies (by internet searches or query emails sent from
one of the authors to the particular institution). University of Southern California has two IRBs with distinct policies, and so was treated as two institutions.
Forty-seven forms were thus left in the analysis.
Second, we then sought to compare hospitals,
schools of medicine, and other health-focused institutions to more general research centers. Because medical research is generally less likely to be exempt than
social science research, we sought to test whether the
nature of form was affected by the type of institution.
Institutions were categorized by name: medical institutions were those with hospital, medical (medicine),
health, or cancer in their names.
Next, we sought to assess the relative time required
of an investigator submitting a full form instead of a
form tailored to exemption by looking at the number
of pages and questions on the respective forms. Two
research assistants located the required forms and
recorded the number of pages and the total number
of questions, and then coded the questions by type.
The coders worked independently, and differences
were resolved by author JL. With the increasing use of
the internet, many institutions use online application
forms, which are usually password protected. Thus,
in many cases forms were not available for assessment-17 institutional exempt forms could be coded,
and 14 full forms. The questions were coded into three
types: checkbox, short answer, and extended answer.
Questions requiring a sentence or less were coded
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"The following information or documentation should be
included or attached for new protocols:justification for exemption (amongst all others)."

as "short;' while those requiring more were coded as
"extended."
The fourth mode of analysis looked at who made
the decision on whether research was exempt. As discussed above, although the regulations do not require
it, DHHS guidance suggests institutions have someone other than the researcher confirm that research
is exempt. There are generally two possibilities: IRB
members or compliance staff. Two authors (JL
DAW) independently coded each of the institutions
into either category, and another author (CR) resolved
any conflicts. Again, four policies could not be found.
Examples are shown in Table 3 below.
Here again, we acknowledge that actual practice may vary from our best reading of the policy; in
&

Carolina - Chapel Hill

Table 2
Examples of

Que tion Language

Question Type

Question Example

Checkbox

"Will this project be registered on
ClinicalTrials.gov?
Yes 0

No O
Short answer

"Name of project"

Extended Answer

"Provide a brief description of the
proposed research using terms
that someone who is not familiar
with the science or discipline can
understand."
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Table 3

Exama

of Decision

r Language

Code

Institution

Form Language

I. IRB member

Washington University in St. Louis

"Only the IRB has the authority to determine if the proposed research activities
qualify as exempt."

2. Compliance staff

University of California, San Francisco

"CHR staff must review your study and certify that it qualifies for exemption."

3. Unclear or both are involved

Yale University

"Research proposals that may qualify for exemption consideration are reviewed by one
or more experienced reviewers who may or
may not be voting members of the IRB."

some but not all cases we confirmed our interpretation by contacting the relevant institution. We used
institutional contextual cues where appropriate. For
example, many institutions referred to their "human
subjects protection programs" (an administrative staff
function) as distinct from their "IRB" (the body of faculty and community members).
Finally, we assessed institutional policy regarding
modifications or amendment to research protocols
previously determined as exempt. When a researcher
modifies the scope or method of research that has been
determined to be exempt from review, that modification could potentially make the research non-exempt.
Some institutions thus have policies requiring investigators to submit modifications for approval as continuing exempt research. We looked to see how many
institutions imposed this additional submission by
coding for policy type, as described in Table 4 below.
This was coded with an identical method to the fourth
mode of analysis.

IV. Results
Our review of the top 50 institutions found that twothirds of institutions have a specific form for researchers to use when they are seeking clearance for exempt
research, and another 15% adapt the full form to focus
on the relevant exemptness-inquiry. However, a significant minority of institutions required the use of
full forms.
Table 5 summarizes our results below. Of the 47
IRBs at 46 institutions for which forms were available,
30 (65.22%) have specific forms for exempt research
applications, 7 (15.22%) required an adapted version
of their main form, 8 (17.39%) require the full IRB
application be used, and 1 (2.17%) required additional
forms as well as the main form. No institution allowed
investigators to proceed with exempt research without submitting a form, which is to say that no institution allows investigators to make the determination
themselves.

Table 4
Modification Codes with Examp
Code

Institution

Form/Policy Language

Any modification requires submission

UC San Diego

"All modifications to a study that has been certified exempt must be submitted to the IRB for prospective review
and certification of exemption prior to implementation."

Only substantive modifications require
submission

UNC Chapel Hill

"Studies that were determined to be exempt at initial
review need not be reviewed again unless substantive
changes warrant review at expedited or full board level."

Only changes that affect exempt status
require submission

University of Michigan

"You are not required to submit an amendment regarding
exempt studies unless the proposed change exceeds the
scope of the exemption category or if ancillary review is
indicated."
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Table 5
Frequency and Percentage of IRB Forms for Exempt Research Applications

Frequency

Percent

Cumulative Percent

No submission

0

0

0

Specific form

31

65.96

65.96

Adapted main form

7

14.89

80.85

Full form

8

17.02

97.87

2.13

100

Code

More than full form
Total

47

100

Table 6
Average Number of Pages and Questions for Form Types

Exempt Form

Full Form

Difference

5.15

18.1

12.95

Total Questions

35

103.3

68.3

Checkbox

13.9

41.3

27.4

ShortAnswer

13.9

35.2

21.3

Extended

7.4

27.4

20

Pages

Table 7
Frequency and Percentage of Exempt Status Decision-Maker

Frequency

Percent

Cumulative Percent

I. IRB member

24

51.06

51.06

2. Compliance staff

II

23.41

74.47

3. Unclear or both
are involved

12

25.53

100

Total

47

100

Code

Table 8
Frequency and Percentage of Modification PolicyTypes

Frequency

Percent

Cumulative Percent

32

66.67

66.67

2. Full submission required for substantive amendments only

6

12.50

79.17

3. Full submission required for changes to exempt status only

10

20.83

100

Total

48

100

Code
1. Full submission required for any amendments
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When considering whether differences existed
between medical-focused and general institutions, as
described in Section III, our sample consisted of 17
medical institutions and 30 general institutions. We
found that 12 (70.59%) medical institutions used a
specific or adapted form, versus 26 (86.67%) general
institutions, meaning 5 (29.41%) medical institutions
use the full form or require even more information
versus 4 (13.33%) of the general institutions. Although
suggestive of a real-world disparity, these differences
are not statistically significant (x2=1.812, p=0.178).
Turning to the difference policy makes, we found
substantially more effort was required of researchers
by the failure to provide a separate form, as shown in

six institutions required submission for substantive
modifications (12.50%). Finally, the third categorythat review was only required when the change would
affect exempt status-was in place at 10 institutions
(20.83%).

V. Discussion
We acknowledge some limitations. We again reiterate that practice may vary from policy. Further, many
of the IRB forms could not be coded because they are
password-protected. This fact may bias our results
because the password-protected online forms may be
'smarter' than paper forms and reduce the number of
questions as appropriate. We did examine instructions

In general, our results suggest a problem of over-compliance: some local
institutions have created burdensome policies beyond that required by the
Federal Common Rule. Although the Common Rule is admittedly intended
to serve as a baseline for institutions, they should be cautious about imposing
additional requirements. This is especially so where those requirements
impose unnecessary and time-wasting demands upon investigators and IRBs,
without corresponding gains for the protection of human subjects.
For exempt research, the risk posed to subjects is minimal.
Table 6. On average, the forms used for a full application were almost 13 pages longer than those designed
specifically for exemption determinations. They
required researchers to answer almost three times as
many questions, and, on average, 20 more extendedresponse questions, which are the most time-consuming for an investigator to answer and for an IRB
member or staffer to review. Depending on where a
researcher happens to work, he or she can experience a quite different process for review of putatively
exempt research.
The analysis of the exemption decision-maker
revealed that the majority of institutions require
review by an actual IRB member (51.06%). When
factoring in the knowledge that some of category 3's
institutions use an initial staff review with confirmation by an IRB member, a clear minority (23.41%) of
institutions rely solely upon compliance staff review.
Table 7 summarizes these results.
For the analysis of amendment or modification
for exempt research, we found that most institutions
required a full amendment application. The first
policy category in which the IRB requires that any
modification to the protocol requires a submission for
review was in place at 32 institutions (66.67%).25 Only

for filling out such forms, and found little evidence of
such smart forms, but cannot rule out the possibility.
Another possible bias is that our selected sample of
top research institutes might be more or less demanding of researchers than the wider population of hundreds of IRBs.
In general, our results suggest a problem of overcompliance: some local institutions have created burdensome policies beyond that required by the Federal Common Rule. Although the Common Rule is
admittedly intended to serve as a baseline for institutions, they should be cautious about imposing additional requirements. This is especially so where those
requirements impose unnecessary and time-wasting
demands upon investigators and IRBs, without corresponding gains for the protection of human subjects. For exempt research, the risk posed to subjects
is minimal.
First, a significant minority of institutions require
investigators to complete full IRB applications when
applying to begin exempt research, which we found
means in practice an average of another 13 pages of
paperwork and answering 68 additional questions.
Moreover, full applications typically require additional information such as scientific review that is
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irrelevant to the determination of whether research is
exempt, adding to the researcher's task. For example,
the Fred Hutchinson Cancer Research Center form
asks researchers: "Is it possible that a commercial
product or patent could result from this study?" and
"What steps will the Principal Investigator of this
study take to ensure that each staff member involved
is adequately informed about the protocol and their
research-related duties and functions-e.g., new staff
orientation, weekly staff meetings?" There may be a
benefit to the institution from some of these queries,
but they are not necessary to determine whether the
study is exempt. These additional requirements not
only take investigators' time to answer the questions,
but can also cause an iterative back-and-forth with
IRB compliance staff, if they require modification of
answers irrelevant to the exemption determination.
Even among those institutions that have specialized
forms, there are wide ranges of application length.
Some institutions have a two-page exempt application, while others require as many as 14. Similarly,
one institution's full application required researchers to answer 178 questions, while another required
28. Some -

but not all -

of this disparity can be

-

explained by compound questions and form structure.
Nevertheless, just as the federal government is subject
to a Paperwork Reduction Act, research universities
should similarly consider and carefully justify paperwork burden.2 6
We received anecdotes from scientists at institutions requiring a full form. They report that they routinely spend seven hours or more preparing the necessary forms, developing the required exhibits and
attachments, securing the relevant signatures including those from department heads and scientific peer
reviewers within their units, and then making revisions based on requests or demands from IRB staff
all simply to obtain an exemption. The process can take
weeks. Our review of the institutional policies makes
these anecdotes appear realistic and ubiquitous.
The analysis of exemption decision-maker reveals
that IRB members are most often called upon to make
decisions about exempt status. In itself, this seems
unobjectionable: there is no evidence that staff can
make a determination on exempt research any quicker
or slower than IRB members, or that they err on the
side of over-compliance more or less. But even if
review by the two groups is of roughly equal accuracy
and speed, there is still a negative effect on research.
Time spent considering exempt protocols may also
delay consideration of other non-exempt proposals,
where there may be substantial risks to human subjects. Further, because the majority of IRB members
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are themselves scientists, this workload creates a secondary burden on science.
Requirements that investigators prepare and submit requests to modify an exempt research project
are in place at a majority of institutions. A substantial
majority of institutions require the submission of a
new application for any changes to the research protocol. This is so even where the change has no bearing on the exempt status, or where the change is of a
minor nature. For example, a researcher using online
surveys in her protocol who had intended to use one
survey service provider when she initially applied but
later wanted to use another platform, would have to
submit another IRB application to do so. On the margin, some researchers might rationally choose to forgo
the paperwork burden and continue using a protocol
that is scientifically suboptimal.
We also found some clear incoherence in the institutional policies. For example, several institutions
require elaborate complete IRB applications for the
initial application, including attachments showing the
survey instrument and securing signatures for scientific peer review. However, once an exemption determination is made, the investigator is allowed to modify the protocol without further submission or review,
unless it would change exemption status, a determination that the investigator is then allowed to make
for herself. Thus, the original survey instrument and
scientific peer review may be utterly irrelevant to the
scientific study ultimately performed.
Reflected in all the avenues of analysis discussed
above is substantial heterogeneity among institutional
policies towards exempt research. The heterogeneity
is unexplained by any logical principle. Although one
justification for IRB flexibility and individual review is
an understanding of local conditions, we were unable
to identify any such meaningful trends.27
Over-compliance is a phenomenon that has been
discussed elsewhere. In the environmental realm,
corporations sometimes lower emissions beyond that
required by regulation. Scholars have presented theoretical models for why companies may do so, if they
can thereby satisfy consumer preferences.28 That is, by
exceeding the required standards, corporations may
be seeking a 'green' reputation.29 This concept loosely
translates to the research realm. While institutions
typically do not advertise their human subjects' protection programs as a point of difference, they can
benefit from strong regimes in the event of research
gone wrong, especially if highly-publicized. Thus, they
may be over-complying as a way of limiting reputational damage. On the other hand, in the market for
scientific talent, institutions must also be careful to
avoid a reputation for being burdensome.
JOURNAL OF LAW, MEDICINE & ETHICS
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It could instead be that DHHS is itself driving this
effect. For example, Shimshack and Ward documented
over-compliance with environmental regulations in
the U.S. pulp and paper industry.30 They found that
enforcement was a significant driver of this phenomenon, provoking many compliant or over-compliant
plants to reduce their discharges even further.31
DHHS enforcement can be severe: after the death of a
subject at Johns Hopkins, OHRP suspended all federally supported research projects at the institution for
several days.32 IRBs are normally nested within wider
research compliance offices, demonstrating the concern with avoiding DHHS enforcement. So it is not
surprising that enforcement actions by DHHS - even
though exceedingly rare and unlikely to be triggered
by putatively exempt research - might be a cause of
institutional over-compliance.
Alternatively, it may be that the over-compliance is
a result of attempts to head off more onerous regulation. In the domain of indigenous rights, for example,
prior research has shown that some states are overcompliant with international treaty obligations, not
out of dedication to the treaty goals, but as a form of
resistance.33 By over-complying with some obligations
(creating "soft rights"), some nations seek to establish
their own vision of indigenous relations and avoid
compliance with other obligations ("hard rights").34
Similarly, IRBs have been criticized for abdicating
their responsibility to develop true ethical standards.35
Seen this way, IRB policies may focus on forms and
procedures as a way of avoiding more substantive
regulations that require them to engage more fully in
hard ethical and scientific questions that might generate more debate.
Finally, but perhaps most likely, some IRBs may
be concerned that the DHHS policy towards exempt
research inadequately protects the human subjects;
they disagree on the merits. These institutions may
be attempting to independently assure that the risk
to subjects is indeed minimal. Or they may be concerned that collecting less information from researchers would allow non-exempt, or risky, research to slip
through the review process. That is, the additional
questions may be designed to prevent omission of
information that might slip through gaps in the main
questions. Thus, the heterogeneity may be driven by
variance in perceptions of the risk to subjects, assessments of the ethical responsibilities of the IRB, or levels of risk-tolerance in individual administrators.
VI. Reforming the Rules
DHHS has proposed reforms. In 2011 it issued an
Advanced Notice of Proposed Rulemaking signaling
changes to the Common Rule,3 6 and in 2015 followed

up with a Notice of Proposed Rulemaking.37 The rules
signal that DHHS has heard some of the criticisms of
the IRB system, and has moved to update the rules to
suit the modern context.38 For example, for multisite

studies, the rules will now require the use of central
IRB review in most cases.3 9

The proposed regulations also alter the categories
of research. First, the previously exempt category for
educational tests, survey procedures, and interview
procedures would now be excluded from the definition of research entirely if nonidentifable, as would
research involving the collection or study of information that has been collected for nonresearch purposes,
and program improvement activities.40
Second, the NPRM adds new categories of exempt
research. Newly exempt research will include research
with nonidentifiable biospecimens if collected with a
broad consent form, research which was previously
not considered human subjects research at all.41 Also
exempt will be benign interventions and collection
of nonidentifiable or nonsensitive identifiable data,
secondary research with identifiable information collected for nonresearch purposes, and survey research
involving identifiable information.42
Finally, and perhaps most relevant to the present
study, the regulations propose a new method of determining whether research is exempt.4 3 Rather than

having institutions individually ascertain exemption
status, the proposed regulations would depend on a
web-based tool to automatically make the determination based on computer-coded logic.44 Investiga-

tors themselves would use the tool, and the result will
protect the institution as long as accurate information
was provided.46 The form would output the informa-

tion provided and the result to allow the institution
to maintain records for this purpose.4 6 Since IRB
members and staff need not be involved in this determination, it could represent a very significant reduction in the workflow for them, and thereby potentially
increase their bandwidth to handle proposals for risky
research.
Importantly, individual institutions may opt-out of
this process.47 They may thereby maintain the troublesome heterogeneity across institutions, and potentially maintain current institutional requests of investigators not required by DHHS.
DHHS has also not specified what this smart form
would actually look like in practice. Thus, it is difficult
to assess the impact of the reform. If the form is tailored to the legally-relevant questions and provides an
immediate approval or denial of exempt status, it will
accelerate scientific research. If the DHHS form, on
the other hand, persists in asking for information that
is irrelevant to the exempt determination (as many
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institutions now do), it may make matters worse off for
investigators currently at more tailored institutions.
The Federal Demonstration Partnership has been
testing an online 'wizard' to make exemption decisions
for member institutions, and DHHS is reportedly
considering the adoption of this wizard after a pilot
period.o The wizard implements many of the principles described above. It guides investigators through
a series of queries designed to elicit only the items key
to whether the research is exempt, such as whether
the information collected will be identifiable. Does the
research involve more than surveys? Will the research
be minimum risk? Generally, the questions are brief,
and easy to understand. Researchers are given a series
of yes/no choices, select the appropriate exemption
type, and within a few minutes have an answer to
whether their research is exempt.
One concern is that some of the questions as currently written involve language taken straight from
the regulations, which thus may require intelligent
interpretation. One plausible reason for the over-compliance phenomenon may be concern about researchers misunderstanding the regulations. Research institutions typically require training of their investigators,
and the exemption tool could itself be a subject of that
training. The upfront time investment in understanding the wizard is likely more beneficial than repeated
completion of a longer application process for the
researcher, and the institutional gains from automated review substantial.
We are hopeful that the new exempt-determination
form will improve the process. Its existence will obviate some of the reasons for over-compliance we identify above, and should limit additional institutional
burden. The pilot wizard appears to be a hopeful step
toward improvement. Still, it has not yet been released
in a final form for comment, and the efficacy of the
proposed reforms turns in part on its quality.
VII. Conclusion
Institutional policies impose constraints on researchers and lead to heterogeneity between institutions.
Accordingly, institutional decisions to deviate from the
Common Rule baseline should require more justification. This is especially so where DHHS itself has recognized the unnecessary burden on exempt research
and proposed changes that would require even less
from institutions than we document here.49 Our data
underlines the need for such reform, and provides
guidance as to its future implementation. Hopefully,
that reform will be finalized as a new version of the
Common Rule, and if so, take advantage of best practices at current IRBs. But in the absence of that regulatory reform, institutions should seize the initiative
490

themselves, and reform their policies to accelerate the
process for valuable exempt research to begin.
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